Merck
MRK
#47
Rank
โ‚น26.437 T
Marketcap
โ‚น10,693
Share price
-0.02%
Change (1 day)
32.06%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): โ‚น637.91

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น684.29. an increase over its 2024 EPS that were of โ‚น633.01.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025โ‚น681.797.71%
2024โ‚น633.014308.46%
2023โ‚น14.36-97.32%
2022โ‚น536.6310.92%
2021โ‚น483.7984.68%
2020โ‚น261.97-27.2%
2019โ‚น359.8363.44%
2018โ‚น220.16151.11%
2017โ‚น87.67-54.58%
2016โ‚น193.0130.21%
2015โ‚น148.23-61.99%
2014โ‚น389.94180.51%
2013โ‚น139.01-31.82%
2012โ‚น203.886.62%
2011โ‚น191.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,043 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น689.28 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น127.37-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น351.10-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,156 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,342 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น193.41-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น278.15-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น352.88-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น116.13-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel